284 related articles for article (PubMed ID: 12197350)
21. Performance of IgG avidity in an area endemic for schistosomiasis in Egypt.
Abou-Basha LM; Shehab AY; Abdel-Fattah M; Bassili A
East Mediterr Health J; 2002 Jan; 8(1):172-80. PubMed ID: 15330573
[TBL] [Abstract][Full Text] [Related]
22. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.
Boisier P; Ramarokoto CE; Ravaoalimalala VE; Rabarijaona L; Serieye J; Roux J; Esterre P
Trans R Soc Trop Med Hyg; 1998; 92(4):451-3. PubMed ID: 9850407
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological studies on Schistosoma mansoni infection in the western region of Saudi Arabia using the potassium hydroxide stool digestion technique.
Ghandour AM; al-Robai AA; Doenhoff M; Banaja AA
J Trop Med Hyg; 1995 Feb; 98(1):57-63. PubMed ID: 7861481
[TBL] [Abstract][Full Text] [Related]
24. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
Rahoud SA; Mergani A; Khamis AH; Saeed OK; Mohamed-Ali Q; Dessein AJ; Elwali NE
FEMS Immunol Med Microbiol; 2010 Feb; 58(1):106-12. PubMed ID: 20030714
[TBL] [Abstract][Full Text] [Related]
25. [Schistosoma mansoni schistosomiasis].
Ranque S; Dessein A
Rev Prat; 2001 Dec; 51(19):2099-103. PubMed ID: 11842728
[TBL] [Abstract][Full Text] [Related]
26. Intestinal schistosomiasis among children in a labour village of Wonji Sugar Estate, Ethiopia.
Simonsen PE; Nega A; Furu P
East Afr Med J; 1990 Aug; 67(8):532-8. PubMed ID: 2124537
[TBL] [Abstract][Full Text] [Related]
27. Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients.
Ruiz-Guevara R; de Noya BA; Valero SK; Lecuna P; Garassini M; Noya O
Rev Soc Bras Med Trop; 2007; 40(5):505-11. PubMed ID: 17992403
[TBL] [Abstract][Full Text] [Related]
28. Hepatic fibrosis due to fascioliasis and/or schistosomiasis in Abis 1 village, Egypt.
Abou-Basha LM; Salem A; Osman M; el-Hefni S; Zaki A
East Mediterr Health J; 2000; 6(5-6):870-8. PubMed ID: 12197343
[TBL] [Abstract][Full Text] [Related]
29. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
[TBL] [Abstract][Full Text] [Related]
30. Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
Zwingenberger K; Harms G; Feldmeier H; Müller O; Steiner A; Bienzle U
Acta Trop; 1988 Sep; 45(3):263-75. PubMed ID: 2903628
[TBL] [Abstract][Full Text] [Related]
31. The epidemiology of schistosomiasis in Egypt: Ismailia governorate.
Nooman ZM; Hasan AH; Waheeb Y; Mishriky AM; Ragheb M; Abu-Saif AN; Abaza SM; Serwah AA; El-Gohary A; Saad A; El-Sayed M; Fouad M
Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):35-41. PubMed ID: 10813498
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
Barakat R; Elmorshedy H; Fenwick A
Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605
[TBL] [Abstract][Full Text] [Related]
33. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.
Mohamed-Ali Q; Doehring-Schwerdtfeger E; Abdel-Rahim IM; Schlake J; Kardorff R; Franke D; Kaiser C; Elsheikh M; Abdalla M; Schafer P
Am J Trop Med Hyg; 1991 Apr; 44(4):444-51. PubMed ID: 1904198
[TBL] [Abstract][Full Text] [Related]
34. Effect of targeted mass treatment on intensity of infection and morbidity in schistosomiasis mansoni: seven-year follow-up of a community in Machakos, Kenya.
DeStigter KV; King CH; Keating CE; Ouma JH; Siongok TK; Mahmoud AA
Trans Assoc Am Physicians; 1989; 102():209-12. PubMed ID: 2517855
[No Abstract] [Full Text] [Related]
35. [Relation between Shistosoma mansoni and hepatosplenomegalies].
Rakotonirina EJ; Andrianjaka P; Rakotoarivelo RA; Ramanampamonjy RM; Randria MJ; Rakotomanga JD
Sante; 2010; 20(1):15-9. PubMed ID: 20350861
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of oral therapy on Mansonial Schistosomiasis using single dose of Balanites aegyptiaca fruits and praziquantel.
Koko WS; Abdalla HS; Galal M; Khalid HS
Fitoterapia; 2005 Jan; 76(1):30-4. PubMed ID: 15664459
[TBL] [Abstract][Full Text] [Related]
37. Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
el-Shafei MM; Mattar MA; Afify HA
J Egypt Soc Parasitol; 2002 Aug; 32(2):551-60. PubMed ID: 12214932
[TBL] [Abstract][Full Text] [Related]
38. Reduction in the prevalence and intensity of hookworm infections after praziquantel treatment for schistosomiasis infection.
Utzinger J; Vounatsou P; N'Goran EK; Tanner M; Booth M
Int J Parasitol; 2002 Jun; 32(6):759-65. PubMed ID: 12062494
[TBL] [Abstract][Full Text] [Related]
39. Rice irrigation and schistosomiasis in savannah and forest areas of Côte d'Ivoire.
Yapi YG; Briët OJ; Diabate S; Vounatsou P; Akodo E; Tanner M; Teuscher T
Acta Trop; 2005 Feb; 93(2):201-11. PubMed ID: 15652334
[TBL] [Abstract][Full Text] [Related]
40. [Neuroschistosomiasis; an unexpected finding in a Dutch woman].
Bouwhuis JW; van der Ven AJ; Gijtenbeek JM; Wesseling P; Sauerwein RW; Beckers PJ
Ned Tijdschr Geneeskd; 2009; 153():A196. PubMed ID: 19785826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
